Anavex Life Sciences Corporation (NASDAQ:AVXL) shares, rose in value, with the stock price down by -3.03% to the previous day’s close as strong demand from buyers drove the stock to $4.48.
Actively observing the price movement in the last trading, the stock closed the session at $4.62. The value of beta (5-year monthly) was 0.58. Referring to stock’s 52-week performance, its high was $10.45, and the low was $4.45. On the whole, AVXL has fluctuated by -10.04% over the past month.
With the market capitalization of Anavex Life Sciences Corporation currently standing at about $367.85 million, investors are eagerly awaiting this quarter’s results, scheduled for May 07, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.11, which is expected to increase to -$0.09 for fiscal year -$0.48 and then to about -$0.64 by fiscal year 2025. Data indicates that the EPS growth is expected to be 20.00% in 2025, while the next year’s EPS growth is forecast to be -33.30%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that AVXL’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of AVXL currently trading nearly -10.36% and -17.27% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.43, while the 7-day volatility ratio is showing 5.73% which for the 30-day chart, stands at 5.74%. Furthermore, Anavex Life Sciences Corporation (AVXL)’s beta value is 0.58, and its average true range (ATR) is 0.31.
A comparison of Anavex Life Sciences Corporation (AVXL) with its peers suggests the former has fared considerably weaker in the market. AVXL showed an intraday change of -3.03% in last session, and over the past year, it shrunk by -47.36%%.
Data on historical trading for Anavex Life Sciences Corporation (NASDAQ:AVXL) indicates that the trading volumes over the past 10 days have averaged 1.14 million and over the past 3 months, they’ve averaged 1.31 million. According to company’s latest data on outstanding shares, there are 82.07 million shares outstanding.
Nearly 3.16% of Anavex Life Sciences Corporation’s shares belong to company insiders and institutional investors own 31.65% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 20.0 million shares as on Mar 15, 2024, resulting in a short ratio of 13.62. According to the data, the short interest in Anavex Life Sciences Corporation (AVXL) stood at 24.36% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 19.89 million. The stock has fallen by -51.88% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AVXL stock heading into the next quarter.
